COA verification is an important distinction from grey-market or research-grade sources, which frequently contain incorrect concentrations or contaminating compounds that cannot be identified without independent testing
Who is generally a candidate Adults 18 and older with a BMI of 30 or higher (obesity), or Adults with a BMI of 27 or higher plus at least one weight-related condition: type 2 diabetes, hypertension, dyslipidemia, or obstructive sleep apnea No disqualifying personal or family medical history (see below) Willing to attend an in-person evaluation and follow-up visits during titration Who we generally do not prescribe to Personal or family history of medullary thyroid carcinoma or MEN2 syndrome (multiple endocrine neoplasia type 2) History of pancreatitis Severe gastroparesis or other significant gastrointestinal motility disease Pregnancy , breastfeeding, or actively planning pregnancy An active eating disorder Known hypersensitivity to semaglutide, tirzepatide, or a formulation's inactive ingredients We also look at what else is driving your case before deciding a GLP-1 is the right tool
Rather than offering a one-size-fits-all solution, we use this foundational information to design a highly customized GLP-1 treatment plan that fits seamlessly into your routine, ensuring the approach is both safe and specifically targeted to help you achieve sustainable, long-term weight loss
GLP-1 class medications have recently grown in popularity
Tirzepatide levocarnitine is a compounded injectable formulation that combines two distinct compounds into a single weekly injection
